CAS: 2072873-06-2

Anti-Human PD-1 Monoclonal Antibody

Sintilimab (IBI308), an IgG4 monoclonal antibody, blocks PD-1, enhancing T-cell anti-tumor response; treats Hodgkin's, lung, and esophageal cancers.